| scholarly article | Q13442814 |
| P2093 | author name string | Ahmed M Malki | |
| Lobna Al-Zaidan | |||
| Rasha Abu El Ruz | |||
| P2860 | cites work | Role of AMP-activated protein kinase in mechanism of metformin action | Q22241898 |
| Metformin in polycystic ovary syndrome: systematic review and meta-analysis | Q22242098 | ||
| Functional annotation of heart enriched mitochondrial genes GBAS and CHCHD10 through guilt by association | Q24301509 | ||
| Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions | Q24532168 | ||
| Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
| Investigating metformin for cancer prevention and treatment: the end of the beginning | Q26863783 | ||
| Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
| Metformin induces unique biological and molecular responses in triple negative breast cancer cells | Q28244833 | ||
| Endonuclease G interacts with histone H2B and DNA topoisomerase II alpha during apoptosis | Q28255246 | ||
| AIF: not just an apoptosis-inducing factor | Q28257046 | ||
| Rb interacts with histone deacetylase to repress transcription | Q28263985 | ||
| Metformin induces apoptosis and cell cycle arrest mediated by oxidative stress, AMPK and FOXO3a in MCF-7 breast cancer cells | Q28539104 | ||
| Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis | Q29615683 | ||
| Metformin and reduced risk of cancer in diabetic patients | Q29616275 | ||
| AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism | Q29617261 | ||
| Otto Warburg's contributions to current concepts of cancer metabolism | Q29617601 | ||
| PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. | Q30658074 | ||
| Graphical exploration of gene expression data: a comparative study of three multivariate methods | Q30906276 | ||
| Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16 | Q33602223 | ||
| Preparation of proteins and peptides for mass spectrometry analysis in a bottom-up proteomics workflow | Q34002643 | ||
| Comparing SILAC- and stable isotope dimethyl-labeling approaches for quantitative proteomics | Q34141777 | ||
| Metformin in cancer prevention and therapy | Q34357983 | ||
| The Rb-related p130 protein controls telomere lengthening through an interaction with a Rad50-interacting protein, RINT-1. | Q34511522 | ||
| Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo. | Q34887704 | ||
| Chemotherapy use and surgical treatment by receptor subtype in node-negative T1a and T1b female breast cancers, Iowa SEER Registry, 2010 to 2012. | Q34899436 | ||
| Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival | Q35688186 | ||
| Metformin in breast cancer - an evolving mystery | Q35780739 | ||
| Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells | Q35884622 | ||
| Extracellular signal-regulated kinases modulate DNA damage response - a contributing factor to using MEK inhibitors in cancer therapy | Q35900578 | ||
| Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts | Q36050677 | ||
| AMPK and p53 help cells through lean times. | Q36212558 | ||
| Down-regulation of α-L-fucosidase 1 expression confers inferior survival for triple-negative breast cancer patients by modulating the glycosylation status of the tumor cell surface | Q36356313 | ||
| Peptides OFFGEL electrophoresis: a suitable pre-analytical step for complex eukaryotic samples fractionation compatible with quantitative iTRAQ labeling | Q36514325 | ||
| Metformin induces apoptosis via a mitochondria-mediated pathway in human breast cancer cells in vitro | Q36824580 | ||
| New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes | Q37319178 | ||
| Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy | Q37463664 | ||
| Glucose promotes breast cancer aggression and reduces metformin efficacy. | Q37525828 | ||
| Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK. | Q37543714 | ||
| Aberrant DNA Double-strand Break Repair Threads in Breast Carcinoma: Orchestrating Genomic Insult Survival | Q37552296 | ||
| Understanding breast cancer - The long and winding road | Q37634220 | ||
| Evaluation of a web-based weight loss intervention in overweight cancer survivors aged 50 years and younger | Q37711173 | ||
| Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena | Q37715626 | ||
| Consideration of GREB1 as a potential therapeutic target for hormone-responsive or endocrine-resistant cancers | Q38226703 | ||
| Identification of a Highly Conserved Allosteric Binding Site on Mnk1 and Mnk2. | Q38844130 | ||
| Pharmacologic Inhibition of MNKs in Acute Myeloid Leukemia. | Q38867428 | ||
| The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention. | Q39030694 | ||
| Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-κB activation | Q39177084 | ||
| Metformin is synthetically lethal with glucose withdrawal in cancer cells. | Q39312255 | ||
| Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro. | Q39346958 | ||
| Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression | Q39357443 | ||
| Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis. | Q39370938 | ||
| Metformin reduces endogenous reactive oxygen species and associated DNA damage | Q39409229 | ||
| The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo | Q39416862 | ||
| Novel 4-(4-aryl)cyclohexyl-1-(2-pyridyl)piperazines as Delta(8)-Delta(7) sterol isomerase (emopamil binding protein) selective ligands with antiproliferative activity | Q39909222 | ||
| The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. | Q40021818 | ||
| Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis. | Q40143359 | ||
| Recent advances in the use of metformin: can treating diabetes prevent breast cancer? | Q41083568 | ||
| Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes | Q42165343 | ||
| Cooperation and competition in the evolution of ATP-producing pathways | Q43562868 | ||
| The GxxxG motif of the transmembrane domain of subunit e is involved in the dimerization/oligomerization of the yeast ATP synthase complex in the mitochondrial membrane | Q44402671 | ||
| Antidiabetic drug metformin induces apoptosis in human MCF breast cancer via targeting ERK signaling | Q46263878 | ||
| Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening | Q46610150 | ||
| The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients. | Q46688906 | ||
| Efficient fractionation and improved protein identification by peptide OFFGEL electrophoresis. | Q51161691 | ||
| Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics. | Q51758332 | ||
| Selective Isolation at the Femtomole Level of Phosphopeptides from Proteolytic Digests Using 2D-NanoLC-ESI-MS/MS and Titanium Oxide Precolumns | Q57666311 | ||
| Metformin increases glucose transporter protein and gene expression in human fibroblasts | Q72547181 | ||
| Prognostic relevance of glycosylation-associated genes in breast cancer | Q87690838 | ||
| Metformin use and improved response to therapy in esophageal adenocarcinoma | Q95405899 | ||
| P921 | main subject | metformin | Q19484 |
| P304 | page(s) | 277 | |
| P577 | publication date | 2017-10-16 | |
| P1433 | published in | Frontiers in Public Health | Q27725050 |
| P1476 | title | Screening Novel Molecular Targets of Metformin in Breast Cancer by Proteomic Approach | |
| P478 | volume | 5 |
| Q90221652 | Metformin-induced apoptosis facilitates degradation of the cellular caspase 8 (FLICE)-like inhibitory protein through a caspase-dependent pathway in human renal cell carcinoma A498 cells |
| Q64934294 | Personalized medicine in breast cancer: pharmacogenomics approaches. |
| Q59138314 | Pleiotropic Effects of Metformin on Cancer |
Search more.